Summary
This article reports on the primary outcomes of the prospective, randomized, single-blind, multicenter EVOLVE II Clinical Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) [EVOLVE II; NCT01665053], which assessed the safety and effectiveness of 2 different everolimus-eluting stents, the second-generation SYNERGY stent and the PROMUS Element Plus durable-polymer drug-eluting stent.
- cardiology clinical trials
- interventional techniques & devices coronary artery disease
- © 2014 MD Conference Express®